EGFR and cancer: By functionalizing the exosome surface with ligands that bind to receptors overexpressed on cancer cells, such as EGFR, HER2, or PSMA, these vesicles can home in on tumor sites with remarkable accuracy (Jiang et al., 2024; Kim R. et al., 2024; Cheng et al., 2023).